Fast Market Research

"Global Critical Care Therapeutics Market 2017-2021" Published

Fast Market Research announces the availability of the new TechNavio report, "Global Critical Care Therapeutics Market 2017-2021", on their comprehensive research portal


Boston, MA -- (SBWIRE) -- 03/24/2017 -- Critical care or intensive care is the close monitoring and treatment given to individuals with acute, life-threatening illness or injuries such as shock, burns, accidents, complicated surgeries, sepsis, and severe breathing problems. It usually takes place in an ICU or trauma center. Plasma is the fluid portion of the blood, in which all the blood cells are suspended. It makes up about 55% of the total volume of the blood. The other components such as red blood cell (RBC), white blood cell (WBC), and platelets together comprise the remaining 45% of the blood. Plasma is mainly made up of water, which accounts for about 91% of the total volume.

Technavio's analysts forecast the global critical care therapeutics market to grow at a CAGR of 3.62% during the period 2017-2021.

Get More Details on this Report and a Full Table of Contents at Global Critical Care Therapeutics Market 2017-2021

Covered in this report
The report covers the present scenario and the growth prospects of the global critical care therapeutics market for 2017-2021. To calculate the market size, the report considers the revenue generated from sales of critical care therapeutics was considered.

The market is divided into the following segments based on geography:


Technavio's report, Global Critical Care Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-CSL Behring
-Kedrion Biopharma

Other prominent vendors

-Abeona Therapeutics
-ADMA Biologics
-Asklepios BioPharmaceutical
-Aspen Pharma
-Bayer HealthCare
-Bio Products Laboratory
-BioDelivery Sciences
-Biogen Idec
-Biotest Pharmaceuticals
-Bristol-Myers Squibb
-Catalyst Biosciences
-China Biologic Products
-Cosmo Pharmaceuticals
-King Pharmaceuticals
-Mitsubishi Tanabe Pharma
-Novo Nordisk
-Portola Pharmaceuticals
-ProMetic Life Sciences
-rEVO Biologics
-Rockwell Medical
-Shanghai RAAS
-Teva Pharmaceutical
-The Medicines Company
-Thermo Fisher Scientific
-Tianjin SinoBiotech & Beijing Bio-Fortune
-Ventria Bioscience

Market driver

-Growing preference for marketed products over alternative treatment options.
-For a full, detailed list, view our report

Market challenge

-Existence of plasma fractionation supply and demand gap.
-For a full, detailed list, view our report

Market trend

-Increased development of recombinant products for critical care use.
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2021 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: CSL Behring, Grifols, Kedrion Biopharma, Octapharma, Shire, Abeona Therapeutics, ADMA Biologics, Albumedix, Armetheon, Asklepios BioPharmaceutical, Aspen Pharma, Baxter, Bayer HealthCare, Bio Products Laboratory, BioDelivery Sciences, Biogen Idec, BioMarin, Biotest Pharmaceuticals, Bristol-Myers Squibb, Catalyst Biosciences, China Biologic Products, Cosmo Pharmaceuticals, Kamada, King Pharmaceuticals, Medxbio, Merck, Mitsubishi Tanabe Pharma, Novo Nordisk, Novozymes, Portola Pharmaceuticals, ProMetic Life Sciences, rEVO Biologics, Rockwell Medical, Sanquin, Shanghai RAAS, Teva Pharmaceutical, The Medicines Company, Thermo Fisher Scientific, Tianjin SinoBiotech & Beijing Bio-Fortune, Ventria Bioscience

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:

-Global Bioactive Wound Care Market 2016-2020
-Fetal (Labor & Delivery) and Neonatal Care Equipment Market - Global Forecast to 2020
-Home Health Care And Residential Nursing Care Services Global Market Report 2017
-Global Metabolic Disorders Therapeutics Market 2016-2020
-Home Health And Residential Nursing Care Services Global Market Report 2016